These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7075183)

  • 1. Pharmacologic maintenance of the ductus arteriosus.
    Freed MD
    Conn Med; 1982 Mar; 46(3):131-4. PubMed ID: 7075183
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment of ductus arteriosus.
    Ivey HH; Wells HH; Kattwinkel J
    Pediatrics; 1980 Apr; 65(4):863. PubMed ID: 7367106
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus].
    Hruda J; Samánek M; First T; Vorísková M; Skovránek J
    Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of prostaglandins and indomethacin in childhood cardiac therapy].
    Gracián M; Castro FJ; Nieves G; Martínez-Villalta E; Mula JA; Guia JM
    An Esp Pediatr; 1988 Sep; 29 Suppl 32():214-7. PubMed ID: 3247946
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology: Prostin VR.
    Hopkins SJ
    Nurs Mirror; 1982 Aug; 155(5):48. PubMed ID: 6921719
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of prostaglandin-E1 on patients with pulmonary atresia (author's transl)].
    Usui K; Kuroda N; Matsukawa S; Sato M; Fukuda M; Ishizawa E
    Kyobu Geka; 1978 Dec; 31(12):908-11. PubMed ID: 723053
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulatory uses of prostaglandins.
    Drug Ther Bull; 1984 Dec; 22(26):101-3. PubMed ID: 6394257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of ductus-dependent congenital heart diseases with prostaglandin E1].
    Lillquist K
    Ugeskr Laeger; 1979 Jul; 141(28):1915-6. PubMed ID: 473414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1].
    Fujii S; Nagai I; Yonei A; Sari A; Baba K
    Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E1 in infants with pulmonary atresia.
    Weir EK; Matisonn RE; Losman E; Chesler E
    S Afr Med J; 1978 Oct; 54(17):700-2. PubMed ID: 741285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
    Silove ED
    Pediatr Cardiol; 1982; 2(4):303-5. PubMed ID: 6956847
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
    Olley PM; Coceani F
    Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS; Nihill MR; Titus JL
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases.
    Calder AL; Kirker JA; Neutze JM; Starling MB
    Pediatr Cardiol; 1984; 5(2):85-92. PubMed ID: 6591146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.